And Gli-1 nuclear expression was identified as a strong and independent predictor of poor response to chemoradiation, early relapse and poor prognosis in ESCC after chemoradiotherapy (CRT) [70,129]. This evidence concerns the gene GLI1 and esophageal squamous cell carcinoma.